Journal Home
Search for

Volume 135, Issue 6, Pages 858-864 (December 2006)


View previous. 13 of 50 View next.

Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer

Ki Chang Keum, MDa, Eun Ji Chung, MDd, Woong Sub Koom, MDa, Jae Ho Cho, MDa, Sang Ho Cho, MDb, Eun Chang Choi, MDc, Chang Geol Lee, MDa, Chang Ok Suh, MDa, Gwi Eon Kim, MD, PhDaCorresponding Author Informationemail address

Objective

In an attempt to identify molecular markers predictive of occult neck metastases, we investigated whether positive p53 or proliferating cell nuclear antigen (PCNA) immunoreactivities on deparaffinized sections of the primary tumor are correlated to the presence of occult neck node metastases in oral tongue cancer patients with clinically negative cervical nodes (N0).

Study design and setting

Between 1986 and 1997, 37 clinically N0 patients who underwent neck dissection (25 male, 12 female; mean age 54 years) were selected for p53 and PCNA staining.

Results

p53 and PCNA immunoreactivities were detected in 68% and 32%, respectively. There was no correlation between p53 or PCNA and other clinicopathological factors, such as tumor differentiation, tumor type, tumor size, and T-stage. Although tumor differentiation (P = 0.03) and tumor size (P = 0.03) were significantly correlated with occult neck metastases of oral tongue cancer by univariate analysis, no correlation was found between p53 or PCNA and the presence of occult neck metastasis.

Conclusion

p53 and/or PCNA expression are unsuitable as biological markers predictive of lymph node metastases of oral tongue cancer.

Significance

p53- or PCNA-positive status are not a reliable parameter for selection of elective neck dissection in the management of N0 oral tongue cancer patients.

a Department of Radiation Oncology, Yonsei Cancer Center, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea

b Department of Pathology, Yonsei University College of Medicine, Seoul, Korea

c Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea

d Department of Radiation Oncology, National Health Insurance Cooperation, Ilsan Hospital, Kyonggi, Korea

Corresponding Author InformationReprint requests: Gwi Eon Kim, MD, PhD, Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seodaemoon-Gu, Shinchon-Dong 134, Seoul 120-752, Korea.

 This work was supported by the Yonsei University Research Fund of 1998.

PII: S0194-5998(06)00163-X

doi:10.1016/j.otohns.2006.02.011


View previous. 13 of 50 View next.